Quantification of crystallinity in substantially amorphous materials by synchrotron X-ray powder diffractometry

被引:120
作者
Nunes, C
Mahendrasingam, A
Suryanarayanan, R
机构
[1] Keele Univ, Dept Phys, Keele ST5 5BG, Staffs, England
[2] Univ Minnesota, Dept Pharmaceut, Minneapolis, MN 55455 USA
关键词
amorphous; crystallinity; pharmaceuticals; synchrotron; X-ray diffraction;
D O I
10.1007/s11095-005-7626-9
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The aim of this study was to develop a highly sensitive powder X-ray diffraction (XRD) technique for quantification of crystallinity in substantially amorphous pharmaceuticals, utilizing synchrotron radiation and a 2-D area detector. Methods. Diffraction data were acquired at the European Synchrotron Radiation Facility (France) using a 2-D charge-coupled device detector. The crystallization of amorphous sucrose was monitored in situ, isothermally at several temperatures in the range of 90 to 160 degrees C. An algorithm was developed for separation of the crystalline and amorphous intensities from the total diffraction pattern. Results. The synchrotron XRD technique allowed powder diffraction patterns to be recorded with a time resolution of 40 ms. The gradual crystallization of sucrose is analogous to a series of physical mixtures with increasing content of the crystalline component. The in situ crystallization approach circumvented the problem of inhomogeneity in mixing-a potentially serious issue at extreme mixture compositions. The estimated limit of detection of crystalline sucrose in an amorphous matrix was 0.2% w/w, a considerable improvement over the reported value of similar to 1% w/w with a conventional XRD. Conclusion. High-intensity XRD can discern subtle changes in the lattice order of materials. The first evidence of crystallization can serve as an indicator of the potential physical instability of the product.
引用
收藏
页码:1942 / 1953
页数:12
相关论文
共 38 条
[1]   ESTIMATION OF DEGREE OF CRYSTALLINITY IN DIGOXIN BY X-RAY AND IR METHODS [J].
BLACK, DB ;
LOVERING, EG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (11) :684-687
[2]   PHARMACEUTICAL SOLIDS - A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS [J].
BYRN, S ;
PFEIFFER, R ;
GANEY, M ;
HOIBERG, C ;
POOCHIKIAN, G .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :945-954
[3]  
Galvan-Sánchez A, 1999, J APPL POLYM SCI, V74, P995, DOI 10.1002/(SICI)1097-4628(19991024)74:4<995::AID-APP26>3.0.CO
[4]  
2-N
[5]   Characteristics and significance of the amorphous state in pharmaceutical systems [J].
Hancock, BC ;
Zograf, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (01) :1-12
[6]   QUANTITATIVE INVESTIGATION OF X-RAY DIFFRACTION BY AMORPHOUS POLYMERS AND SOME OTHER NONCRYSTALLINE SUBSTANCES [J].
HERMANS, PH ;
WEIDINGER, A .
JOURNAL OF POLYMER SCIENCE, 1950, 5 (03) :269-281
[7]   QUANTITATIVE X-RAY INVESTIGATIONS ON THE CRYSTALLINITY OF CELLULOSE FIBERS - A BACKGROUND ANALYSIS [J].
HERMANS, PH ;
WEIDINGER, A .
JOURNAL OF APPLIED PHYSICS, 1948, 19 (05) :491-506
[8]   An instrument for the collection of simultaneous small and wide angle x-ray scattering and stress-strain data during deformation of polymers at high strain rates using synchrotron radiation sources [J].
Hughes, DJ ;
Mahendrasingam, A ;
Martin, C ;
Oatway, WB ;
Heeley, EL ;
Bingham, SJ ;
Fuller, W .
REVIEW OF SCIENTIFIC INSTRUMENTS, 1999, 70 (10) :4051-4054
[9]  
IMAIZUMI H, 1980, CHEM PHARM BULL, V28, P2565
[10]  
*INT CTR DIFFR DAT, 1998, POWD DIFFR FIL PDF 2